Prevention Strategies to Minimize the Infection Risk Associated with Biologic and Targeted Immunomodulators

The introduction of biologic and targeted immunomodulators is a significant breakthrough in the therapeutic area of various fields of medicine. The occurrence of serious infections, a complication of secondary immunosuppression associated with these agents, leads to increased morbidity and mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Kordzadeh-Kermani, Elaheh, Khalili, Hossein, Karimzadeh, Iman, Salehi, Mohammadreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035951/
https://www.ncbi.nlm.nih.gov/pubmed/32110062
http://dx.doi.org/10.2147/IDR.S233137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035951/
https://www.ncbi.nlm.nih.gov/pubmed/32110062
http://dx.doi.org/10.2147/IDR.S233137

Ejemplares similares